D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 70 Citations 17,039 159 World Ranking 15961 National Ranking 678

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Myocardial infarction
  • Cardiology

His scientific interests lie mostly in Internal medicine, Cardiology, Radiology, Surgery and Coronary atherosclerosis. His study involves Angiography, Myocardial infarction, Infarction, Revascularization and Coronary arteries, a branch of Internal medicine. His study in Angina, Coronary artery disease, Ejection fraction, Stenosis and Artery is carried out as part of his Cardiology studies.

Within one scientific family, Jacques Lespérance focuses on topics pertaining to Blood pressure under Artery, and may sometimes address concerns connected to Clinical trial, Diameter stenosis and Right coronary artery. His biological study focuses on Intravascular ultrasound. His Coronary atherosclerosis research integrates issues from Atheroma and Cholesterol.

His most cited work include:

  • Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. (620 citations)
  • Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. (602 citations)
  • Clinical, angiographic, and hemodynamic findings in patients with anomalous origin of the coronary arteries. (380 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Cardiology, Surgery, Radiology and Artery. Coronary artery disease, Myocardial infarction, Coronary atherosclerosis, Angina and Ejection fraction are the subjects of his Internal medicine studies. His research integrates issues of Restenosis and Angiography in his study of Cardiology.

His work deals with themes such as Coronary angiography, Lumen and Reproducibility, which intersect with Radiology. His Artery research is multidisciplinary, incorporating perspectives in Blood flow and Pulmonary artery. As a member of one scientific family, he mostly works in the field of Coronary arteries, focusing on Right coronary artery and, on occasion, Percutaneous coronary intervention.

He most often published in these fields:

  • Internal medicine (71.52%)
  • Cardiology (69.54%)
  • Surgery (33.11%)

What were the highlights of his more recent work (between 2003-2021)?

  • Internal medicine (71.52%)
  • Cardiology (69.54%)
  • Radiology (29.14%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Cardiology, Radiology, Artery and Surgery. His Internal medicine study is mostly concerned with Myocardial infarction, Coronary atherosclerosis, Acute coronary syndrome, Angina and Coronary arteries. The various areas that Jacques Lespérance examines in his Coronary atherosclerosis study include Atheroma and Cholesterol.

His work on Coronary artery disease, Percutaneous coronary intervention, Intravascular ultrasound and Coronary angiography as part of general Cardiology study is frequently linked to In patient, bridging the gap between disciplines. His studies in Radiology integrate themes in fields like Anomaly and Cardiac catheterization. His research in the fields of Vascular Patency overlaps with other disciplines such as Term.

Between 2003 and 2021, his most popular works were:

  • Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. (602 citations)
  • Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions (243 citations)
  • Depression, C-reactive Protein and Two-year Major Adverse Cardiac Events in Men after Acute Coronary Syndromes (104 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.

Leonard Schwartz;Martial G. Bourassa;Jacques Lespérance;Harold E. Aldridge.
The New England Journal of Medicine (1988)

986 Citations

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.

J C Tardif;G Cöté;J Lespérance;M Bourassa.
The New England Journal of Medicine (1997)

915 Citations

The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

Lucien Campeau;Marc Enjalbert;Jacques Lespérance;Martial G. Bourassa.
The New England Journal of Medicine (1984)

854 Citations

Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation.

C M Grondin;L Campeau;J Lesperance;M Enjalbert.
Circulation (1984)

742 Citations

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

Jean-Claude Tardif;Jean Grégoire;Philippe L. L’Allier;Reda Ibrahim.
JAMA (2007)

613 Citations

Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery.

Campeau L;Enjalbert M;Lespérance J;Vaislic C.
Circulation (1983)

578 Citations

Clinical, angiographic, and hemodynamic findings in patients with anomalous origin of the coronary arteries.

B R Chaitman;J Lespérance;J Saltiel;M G Bourassa.
Circulation (1976)

577 Citations

A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.

D Waters;J Lespérance;M Francetich;D Causey.
Circulation (1990)

509 Citations

Discrepancies Between Cineangiographic and Postmortem Findings in Patients with Coronary Artery Disease and Recent Myocardial Revascularization

Claude M. Grondin;Ihor Dyrda;André Pasternac;Lucien Campeau.
Circulation (1974)

456 Citations

Prognostic significance of progression of coronary atherosclerosis.

D Waters;T E Craven;J Lespérance.
Circulation (1993)

375 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jacques Lespérance

Patrick W. Serruys

Patrick W. Serruys

National University of Ireland, Galway

Publications: 90

Valentin Fuster

Valentin Fuster

Icahn School of Medicine at Mount Sinai

Publications: 77

Stephen J. Nicholls

Stephen J. Nicholls

Monash University

Publications: 76

Jean-Claude Tardif

Jean-Claude Tardif

Montreal Heart Institute

Publications: 69

Eric J. Topol

Eric J. Topol

Scripps Research Institute

Publications: 57

Steven E. Nissen

Steven E. Nissen

Cleveland Clinic

Publications: 57

David R. Holmes

David R. Holmes

Mayo Clinic

Publications: 54

Robert M. Califf

Robert M. Califf

Duke University

Publications: 53

Martial G. Bourassa

Martial G. Bourassa

Montreal Heart Institute

Publications: 45

Johan H. C. Reiber

Johan H. C. Reiber

Leiden University Medical Center

Publications: 45

Martin B. Leon

Martin B. Leon

Columbia University Medical Center

Publications: 40

Pim J. de Feyter

Pim J. de Feyter

Erasmus University Rotterdam

Publications: 39

Stephen G. Ellis

Stephen G. Ellis

Cleveland Clinic

Publications: 37

Gianni D. Angelini

Gianni D. Angelini

University of Bristol

Publications: 35

Jeffrey J. Popma

Jeffrey J. Popma

Beth Israel Deaconess Medical Center

Publications: 34

E. Murat Tuzcu

E. Murat Tuzcu

Cleveland Clinic

Publications: 32

Trending Scientists

Anthony Stentz

Anthony Stentz

Carnegie Mellon University

Ramakant Nevatia

Ramakant Nevatia

University of Southern California

Simon J. Teat

Simon J. Teat

Lawrence Berkeley National Laboratory

Haralampos N. Miras

Haralampos N. Miras

University of Glasgow

Lindell Bromham

Lindell Bromham

Australian National University

A. H. Reddi

A. H. Reddi

University of California, Davis

John C. Fry

John C. Fry

Cardiff University

Peter W. Swaan

Peter W. Swaan

University of Maryland, Baltimore

Masanori Baba

Masanori Baba

Kagoshima University

Bente Pakkenberg

Bente Pakkenberg

University of Copenhagen

Ian J. Kirk

Ian J. Kirk

University of Auckland

Hiroichi Nagai

Hiroichi Nagai

Gifu Pharmaceutical University

Paul Brennan

Paul Brennan

University of Edinburgh

Achille C. Pessina

Achille C. Pessina

University of Padua

Stefano Fiorucci

Stefano Fiorucci

University of Perugia

C. Rubbia

C. Rubbia

European Organization for Nuclear Research

Something went wrong. Please try again later.